Evidence map›Paper›PMID 40284463›Full record

ArticlePharmaceutics2025

C3-Liposome Delivery of MUC1 Peptide and TLR Agonists Enhances Adaptive Immunity and Results in Sex-Based Tumor Growth Differences.

Shahab Soltani, Ameneh Arabi, Kristine Mann, Austin Hess, Holly A Martinson, Max Kullberg

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceutics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Shahab SoltaniWWAMI School of Medical Education, University of Alaska Anchorage, 3211 Providence Drive, Anchorage, AK 99508, USA.
Ameneh ArabiWWAMI School of Medical Education, University of Alaska Anchorage, 3211 Providence Drive, Anchorage, AK 99508, USA.
Kristine MannDepartment of Biological Sciences, University of Alaska Anchorage, Anchorage, AK 99508, USA.
Austin HessWWAMI School of Medical Education, University of Alaska Anchorage, 3211 Providence Drive, Anchorage, AK 99508, USA.
Holly A MartinsonWWAMI School of Medical Education, University of Alaska Anchorage, 3211 Providence Drive, Anchorage, AK 99508, USA.ORCID 0000-0003-2745-2755
Max KullbergWWAMI School of Medical Education, University of Alaska Anchorage, 3211 Providence Drive, Anchorage, AK 99508, USA.

Funding

The Administrative CoreP20GM103395 · NIGMS · UNIVERSITY OF ALASKA FAIRBANKS · PI BRIAN M BARNES · 2012 to 2026
$66.1M
Enhancing Tumor Antigen Presentation with Complement Targeted NanoparticlesR15CA227740 · NCI · UNIVERSITY OF ALASKA ANCHORAGE · PI KULLBERG, MAX PETER, MARTINSON, HOLLY A · 2018 to 2022
$937k
NCI NIH HHS R15 CA227740NIGMS NIH HHS P20 GM103395
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

adjuvantsantigen-presenting cellcancer immunotherapycomplement C3Lewis lung carcinomaliposomemucin-1nanoparticletargeted deliverytoll-like receptorvaccine

Identifiers

PMID40284463
PMCPMC12030583

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.